113 related articles for article (PubMed ID: 33526472)
1. The 20S proteasome activator PA28γ controls the compaction of chromatin.
Fesquet D; Llères D; Grimaud C; Viganò C; Méchali F; Boulon S; Coux O; Bonne-Andrea C; Baldin V
J Cell Sci; 2021 Feb; 134(3):. PubMed ID: 33526472
[TBL] [Abstract][Full Text] [Related]
2. PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ.
Jonik-Nowak B; Menneteau T; Fesquet D; Baldin V; Bonne-Andrea C; Méchali F; Fabre B; Boisguerin P; de Rossi S; Henriquet C; Pugnière M; Ducoux-Petit M; Burlet-Schiltz O; Lamond AI; Fort P; Boulon S; Bousquet MP; Coux O
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6477-E6486. PubMed ID: 29934401
[TBL] [Abstract][Full Text] [Related]
3. PA28γ: New Insights on an Ancient Proteasome Activator.
Cascio P
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562807
[TBL] [Abstract][Full Text] [Related]
4. Evidence for low nanocompaction of heterochromatin in living embryonic stem cells.
Dupont C; Chahar D; Trullo A; Gostan T; Surcis C; Grimaud C; Fisher D; Feil R; Llères D
EMBO J; 2023 Jun; 42(12):e110286. PubMed ID: 37082862
[TBL] [Abstract][Full Text] [Related]
5. N-terminal HCV core protein fragment decreases 20S proteasome activity in the presence of PA28γ.
Zheng Y; Shimamoto S; Maruno T; Kobayashi Y; Matsuura Y; Kawahara K; Yoshida T; Ohkubo T
Biochem Biophys Res Commun; 2019 Feb; 509(2):590-595. PubMed ID: 30602418
[TBL] [Abstract][Full Text] [Related]
6. Proteasome activator PA28γ stimulates degradation of GSK3-phosphorylated insulin transcription activator MAFA.
Kanai K; Aramata S; Katakami S; Yasuda K; Kataoka K
J Mol Endocrinol; 2011 Aug; 47(1):119-127. PubMed ID: 21830322
[TBL] [Abstract][Full Text] [Related]
7. PA28γ-20S proteasome is a proteolytic complex committed to degrade unfolded proteins.
Frayssinhes JA; Cerruti F; Laulin J; Cattaneo A; Bachi A; Apcher S; Coux O; Cascio P
Cell Mol Life Sci; 2021 Dec; 79(1):45. PubMed ID: 34913092
[TBL] [Abstract][Full Text] [Related]
8. Proteasome activator 28γ (PA28γ) allosterically activates trypsin-like proteolysis by binding to the α-ring of the 20S proteasome.
Thomas TA; Smith DM
J Biol Chem; 2022 Aug; 298(8):102140. PubMed ID: 35714770
[TBL] [Abstract][Full Text] [Related]
9. A novel role for PA28gamma-proteasome in nuclear speckle organization and SR protein trafficking.
Baldin V; Militello M; Thomas Y; Doucet C; Fic W; Boireau S; Jariel-Encontre I; Piechaczyk M; Bertrand E; Tazi J; Coux O
Mol Biol Cell; 2008 Apr; 19(4):1706-16. PubMed ID: 18256291
[TBL] [Abstract][Full Text] [Related]
10. The proteasome activator PA28γ, a negative regulator of p53, is transcriptionally up-regulated by p53.
Wan ZX; Yuan DM; Zhuo YM; Yi X; Zhou J; Xu ZX; Zhou JL
Int J Mol Sci; 2014 Feb; 15(2):2573-84. PubMed ID: 24531141
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes.
Welk V; Coux O; Kleene V; Abeza C; Trümbach D; Eickelberg O; Meiners S
J Biol Chem; 2016 Jun; 291(25):13147-59. PubMed ID: 27129254
[TBL] [Abstract][Full Text] [Related]
12. Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.
Zhang H; Tu J; Cao C; Yang T; Gao L
Biochem Biophys Res Commun; 2020 Aug; 529(2):251-256. PubMed ID: 32703419
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy by proteasome activator, PA28γ, improves motor coordination and proteasome function in Huntington's disease YAC128 mice.
Jeon J; Kim W; Jang J; Isacson O; Seo H
Neuroscience; 2016 Jun; 324():20-8. PubMed ID: 26944602
[TBL] [Abstract][Full Text] [Related]
14. Atomic resolution Cryo-EM structure of human proteasome activator PA28γ.
Chen DD; Hao J; Shen CH; Deng XM; Yun CH
Int J Biol Macromol; 2022 Oct; 219():500-507. PubMed ID: 35932807
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of proteasome and immunoproteasome regulators Pa28αβ, Pa28γ and Pa200 in the degradation of oxidized proteins.
Pickering AM; Davies KJ
Arch Biochem Biophys; 2012 Jul; 523(2):181-90. PubMed ID: 22564544
[TBL] [Abstract][Full Text] [Related]
16. Proteasome-dependent degradation of histone H1 subtypes is mediated by its C-terminal domain.
García-Gomis D; López J; Calderón A; Andrés M; Ponte I; Roque A
Protein Sci; 2024 May; 33(5):e4970. PubMed ID: 38591484
[TBL] [Abstract][Full Text] [Related]
17. Evidence for anti-apoptotic roles of proteasome activator 28γ via inhibiting caspase activity.
Moncsek A; Gruner M; Meyer H; Lehmann A; Kloetzel PM; Stohwasser R
Apoptosis; 2015 Sep; 20(9):1211-28. PubMed ID: 26201457
[TBL] [Abstract][Full Text] [Related]
18. Mammalian HP1 Isoforms Have Specific Roles in Heterochromatin Structure and Organization.
Bosch-Presegué L; Raurell-Vila H; Thackray JK; González J; Casal C; Kane-Goldsmith N; Vizoso M; Brown JP; Gómez A; Ausió J; Zimmermann T; Esteller M; Schotta G; Singh PB; Serrano L; Vaquero A
Cell Rep; 2017 Nov; 21(8):2048-2057. PubMed ID: 29166597
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein stimulates cell growth by downregulating p16 levels via PA28γ-mediated proteasomal degradation.
Cha S; Jang KL
J Gen Virol; 2020 Sep; 101(9):963-971. PubMed ID: 32568029
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis of Heterochromatin Formation by Human HP1.
Machida S; Takizawa Y; Ishimaru M; Sugita Y; Sekine S; Nakayama JI; Wolf M; Kurumizaka H
Mol Cell; 2018 Feb; 69(3):385-397.e8. PubMed ID: 29336876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
